Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human serum albumin versus human serum albumin in cirrhosis with ascites
ChiCTR2300078168Phase 2Completed
- Sponsor
- Beijing Friendship Hospital
- Start
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of recombinant human serum albumin in Cirrhosis and ascites (4 arms), sponsored by Beijing Friendship Hospital. Primary endpoint: Change in serum albumin concentration from baseline after completion of last administration. Started Sep 2021; status: completed.
02
Drugs
recombinant human serum albumin
03
Conditions
Cirrhosisascites
Beyond the preview
Go deeper on ChiCTR2300078168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078168.